5 stocks to watch on Wednesday: Tesla, Abbott Labs, P&G and more
JasonDoiy
U.S. stock index futures on Wednesday pointed to a lower open, as geopolitical concerns weighed on sentiment following an escalation in the ongoing conflict between Israel and Islamist group Hamas. At home, the Q3 earnings season continued to ramp up. Here are some stocks to watch on Wednesday: 

There will be significant attention on Tesla (NASDAQ:TSLA) stock, with the electric vehicle leader on tap to report Q3 results after the closing bell. The company is expected to earn 73 cents per share on revenue of $24.14B. Eyes will be on the company's deliveries guidance and margin outlook, along with any updates on the Cybertruck and its Gigafactory plans. The Elon Musk-led firm earlier this month said it produced 430,488 vehicles and delivered 435,059 vehicles during Q3, with the former number declining sequentially.
Abbott Laboratories (ABT) stock was among the most actively traded ahead of the opening bell, rising more than 3%. The medical device maker reported a Q3 top and bottom line beat, as a plunge in sales in its diagnostics business was offset by growth in its other units. ABT top boss Robert Ford said that the investments made by the company during the COVID-19 pandemic was continuing to drive "broad-based growth." ABT also narrowed its full year 2023 adjusted earnings per share guidance. See how ABT performed in charts.
Shares of Morgan Stanley (MS) were also among the most actively traded ahead of market open, falling more than 3%. The lender beat estimates on top and bottom line, but its Q3 net interest income came in short of Wall Street expectations, despite elevated interest rates. Moreover, muted merger and acquisition activity along with a higher-than-anticipated provision for credit losses weighed on investors. MS CEO James Gorman noted that the market environment "remained mixed" in Q3.
Procter & Gamble (PG) stock added more than 1% in pre-market trading, after the owner of popular brands such as Gillette, Pampers, Pantene and Ariel smashed FQ1 2024 organic sales expectations with a 7% increase. The company's performance was helped by higher pricing, though volume fell 1%. PG chief executive Jon Moeller said the results put the firm on track to deliver towards the higher end of its fiscal year guidance ranges for organic sales and core earnings per share. See how PG performed in charts.
Shares of Netflix (NFLX) will be in focus, with the streaming giant scheduled to announce Q3 numbers after the closing bell. Wall Street expects the company to earn $3.49 per share on revenue of $8.54B. Netflix's (NFLX) Q2 report back in July disappointed investors after it showed a miss on revenue, despite subscriber additions coming in more than estimated. Executives on the earnings call had said that paid sharing was key to ramping up sales in 2023, and investors will be looking out for more comments on that.

More on the markets 

Biggest stock movers today: United Airlines, Viking Therapeutics and more
A recession is the most likely outcome in 2024 - Russell Investments
Consumer Spending Shows Soft Landing On Track
Geopolitical Tensions Lift Oil And Gold, But Little Sign Of Haven Buying In FX
Rising Instability And Its Market Impacts